Compare Medtronic PLC (MDT) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs TotalEnergies SE — how do they compare? Medtronic PLC trades at $83.21 (market cap $106.61B), while TotalEnergies SE trades at $82.51 (market cap $179.99B). The key difference: TotalEnergies SE is the larger of the two by market cap, and TotalEnergies SE pays the higher dividend (5.22%). Which is the better fit depends on your goals.
| MDT | TTE | |
|---|---|---|
Market Cap | $106.61B | $179.99B |
Sector | Health | Energy |
52-Week High | $105.35 | $93.60 |
52-Week Low | $73.75 | $57.39 |
Enterprise Value | $125.36B | $214.14B |
Dividend Yield | 3.46% | 5.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
TotalEnergies (TTE) trades at $81.23, down 0.2% on the day, with a bullish technical signal supported by moving averages. The company reported a Q1 2026 EPS beat of $2.45 versus $2.22 expected, though revenue has declined from $263.3B in 2022 to $182.3B in 2025. Valuation remains attractive with a P/E of 12.08 and P/S of 0.97. Recent news highlights strategic divestments in solar and new LNG shipments to Asia, reflecting a focus on profitable growth areas.
The outlook is positive with a consensus price target of $100, implying 23% upside, supported by 57.6% analyst buy ratings. Risks include ongoing revenue pressure, geopolitical exposure in the Middle East, and regulatory climate mandates. Cash flow stability and shareholder returns via dividends provide a cushion, but execution on production growth and cost management is critical for sustained appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
